Thought leader Stanley Lapidus is President, CEO and Co-founder of Helicos BioSciences, a company that is developing instruments for high-speed sequencing of DNA or RNA without amplification. He believes the pharma interest is not necessarily in owning a diagnostic test; it’s making sure that the test is out there and in capable hands, whether it’s a diagnostics company or testing laboratory or both.